OBJECTIVE: Data supporting the use of perioperative steroids during cardiac surgery are conflicting, and most pediatric studies have been limited by small sample sizes and/or diverse cardiac diagnoses. The objective of this study was to determine if intraoperative steroid administration improved outcomes following the Norwood procedure. DESIGN: A retrospective analysis was performed on the 549 neonates who underwent a Norwood procedure in the publicly available datasets from the Pediatric Heart Network's Single Ventricle Reconstruction trial. Groups were compared to determine if outcomes differed between intraoperative steroid recipients (n = 498, 91%) and nonrecipients (n = 51, 9%). SETTING:Fifteen North American centers. SUBJECTS:Infants enrolled in the Single Ventricle Reconstruction trial. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Baseline characteristics and intraoperative variables were similar between groups with the exception of a shorter duration of cross clamp and cardiopulmonary bypass time in the group that received steroids. Subjects who did not receive intraoperative steroids had improved hospital survival (94% vs 83%, p = 0.03) but longer ICU stays (16 d; interquartile range, 12-33 vs 14 d; interquartile range, 9-28; p = 0.04) and hospital stays (29 d; interquartile range, 21-50 vs 23 d; interquartile range, 15-40; p = 0.01) than steroid recipients. In multivariate analysis, lengths of stay associations were no longer significant, but hospital survival trended toward favoring the nonsteroid group with an odds ratio of 3.52 (95% CI, 0.98-12.64; p = 0.054). CONCLUSIONS: In the large multicentered Single Ventricle Reconstruction trial, there was widespread use of intraoperative steroids. Intraoperative steroid administration was not associated with an improvement in outcomes and may be associated with a reduction in hospital survival in neonates undergoing the Norwood procedure. This study highlights the need for a randomized control trial.
RCT Entities:
OBJECTIVE: Data supporting the use of perioperative steroids during cardiac surgery are conflicting, and most pediatric studies have been limited by small sample sizes and/or diverse cardiac diagnoses. The objective of this study was to determine if intraoperative steroid administration improved outcomes following the Norwood procedure. DESIGN: A retrospective analysis was performed on the 549 neonates who underwent a Norwood procedure in the publicly available datasets from the Pediatric Heart Network's Single Ventricle Reconstruction trial. Groups were compared to determine if outcomes differed between intraoperative steroid recipients (n = 498, 91%) and nonrecipients (n = 51, 9%). SETTING: Fifteen North American centers. SUBJECTS:Infants enrolled in the Single Ventricle Reconstruction trial. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Baseline characteristics and intraoperative variables were similar between groups with the exception of a shorter duration of cross clamp and cardiopulmonary bypass time in the group that received steroids. Subjects who did not receive intraoperative steroids had improved hospital survival (94% vs 83%, p = 0.03) but longer ICU stays (16 d; interquartile range, 12-33 vs 14 d; interquartile range, 9-28; p = 0.04) and hospital stays (29 d; interquartile range, 21-50 vs 23 d; interquartile range, 15-40; p = 0.01) than steroid recipients. In multivariate analysis, lengths of stay associations were no longer significant, but hospital survival trended toward favoring the nonsteroid group with an odds ratio of 3.52 (95% CI, 0.98-12.64; p = 0.054). CONCLUSIONS: In the large multicentered Single Ventricle Reconstruction trial, there was widespread use of intraoperative steroids. Intraoperative steroid administration was not associated with an improvement in outcomes and may be associated with a reduction in hospital survival in neonates undergoing the Norwood procedure. This study highlights the need for a randomized control trial.
Authors: A J Alcaraz; L Sancho; L Manzano; F Esquivel; A Carrillo; A Prieto; E D Bernstein; M Alvarez-Mon Journal: J Thorac Cardiovasc Surg Date: 2002-03 Impact factor: 5.209
Authors: Sarah Tabbutt; Nancy Ghanayem; Chitra Ravishankar; Lynn A Sleeper; David S Cooper; Deborah U Frank; Minmin Lu; Christian Pizarro; Peter Frommelt; Caren S Goldberg; Eric M Graham; Catherine Dent Krawczeski; Wyman W Lai; Alan Lewis; Joel A Kirsh; Lynn Mahony; Richard G Ohye; Janet Simsic; Andrew J Lodge; Ellen Spurrier; Mario Stylianou; Peter Laussen Journal: J Thorac Cardiovasc Surg Date: 2012-06-15 Impact factor: 5.209
Authors: Sara K Pasquali; Matthew Hall; Jennifer S Li; Eric D Peterson; James Jaggers; Andrew J Lodge; Bradley S Marino; Denise M Goodman; Samir S Shah Journal: Circulation Date: 2010-11-08 Impact factor: 29.690
Authors: Richard G Ohye; J William Gaynor; Nancy S Ghanayem; Caren S Goldberg; Peter C Laussen; Peter C Frommelt; Jane W Newburger; Gail D Pearson; Sarah Tabbutt; Gil Wernovsky; Lisa M Wruck; Andrew M Atz; Steve D Colan; James Jaggers; Brian W McCrindle; Ashwin Prakash; Michael D Puchalski; Lynn A Sleeper; Mario P Stylianou; Lynn Mahony Journal: J Thorac Cardiovasc Surg Date: 2008-05-19 Impact factor: 5.209
Authors: William T Mahle; Emilia Matthews; Kirk R Kanter; Brian E Kogon; Shannon E G Hamrick; Matthew J Strickland Journal: Ann Thorac Surg Date: 2014-01-11 Impact factor: 4.330
Authors: James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle Journal: Circulation Date: 2017-07-07 Impact factor: 29.690
Authors: Eric M Graham; Reneé H Martin; Jason R Buckley; Sinai C Zyblewski; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Marc Hassid; Andrew M Atz Journal: J Am Coll Cardiol Date: 2019-08-06 Impact factor: 24.094
Authors: Daniel P Fudulu; Ben Gibbison; Thomas Upton; Serban C Stoica; Massimo Caputo; Stafford Lightman; Gianni D Angelini Journal: Front Pediatr Date: 2018-04-20 Impact factor: 3.418
Authors: Luregn J Schlapbach; Stephen Brian Horton; Debbie Amanda Long; John Beca; Simon Erickson; Marino Festa; Yves d'Udekem; Nelson Alphonso; David Winlaw; Kerry Johnson; Carmel Delzoppo; Kim van Loon; B Gannon; Jonas Fooken; Antje Blumenthal; Paul Young; Mark Jones; Warwick Butt; Andreas Schibler Journal: BMJ Open Date: 2019-08-15 Impact factor: 2.692